National Center for Complementary and Alternative Medicine; Notice of Meeting, 19498-19499 [2013-07421]
Download as PDF
<![CDATA[
19498
Federal Register / Vol. 78, No. 62 / Monday, April 1, 2013 / Notices
Dated: March 26, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–07419 Filed 3–29–13; 8:45 am]
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
pmangrum on DSK3VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Biobehavioral and Behavioral
Sciences Subcommittee.
Date: April 25, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Washington Plaza Hotel, 10
Thomas Circle NW., Washington, DC 20005.
Contact Person: Marita R. Hopmann, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health And
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
301–435–6911, hopmannm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 26, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–07422 Filed 3–29–13; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
15:34 Mar 29, 2013
Jkt 229001
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Neurological Sciences
Training Initial Review Group; NST–1
Subcommittee.
Date: June 10–11, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Best Western Tuscan Inn, 425 North
Point Street, San Francisco, CA 94133.
Contact Person: Raul A. Saavedra, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS, NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–496–9223,
saavedrr@ninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders C.
Date: June 20–21, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel & Spa, 1600 King
Street, Alexandria, VA 22314.
Contact Person: William C. Benzing, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS, NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–496–0660,
benzingw@mail.nih.gov.
Name of Committee: Neurological Sciences
Training Initial Review Group; NST–2
Subcommittee.
Date: June 24–25, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW., Washington, DC 20037.
Contact Person: JoAnn McConnell, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS, NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
9529, 301–435–6033,
mcconnej@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated:March 26, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–07425 Filed 3–29–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Alternative Medicine; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council for
Complementary and Alternative
Medicine.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Complementary and Alternative
Medicine.
Date: June 7, 2013.
Closed: 8:30 a.m. to 10:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Open: 10:15 a.m. to 4:00 p.m.
Agenda: Report from the Institute Director
and other business of the Council.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
E:\FR\FM\01APN1.SGM
01APN1
Federal Register / Vol. 78, No. 62 / Monday, April 1, 2013 / Notices
Contact Person: Martin H. Goldrosen,
Ph.D., Director, Division of Extramural
Activities, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Ste. 401,
Bethesda, MD 20892–5475, (301) 594–2014,
goldrosm@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
nccam.nih.gov/about/naccam/, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Minna Liang, Ph.D.,
Scientific Review Officer, Grants Review
Branch, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, 6001 Executive Blvd., Room 4226,
MSC 9550, Bethesda, MD 20892–9550, 301–
435–1432, liangm@nida.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: March 26, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
National Institutes of Health
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
pmangrum on DSK3VPTVN1PROD with NOTICES
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel PAR–
12–297: Mechanism for Time-Sensitive Drug
Abuse Research.
Date: April 9, 2013.
Time: 12:00 p.m. to 2:00 p.m.
15:34 Mar 29, 2013
Jkt 229001
[FR Doc. 2013–07424 Filed 3–29–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute on Drug Abuse;
Notice of Closed Meeting
[FR Doc. 2013–07421 Filed 3–29–13; 8:45 am]
VerDate Mar<15>2010
Dated: March 26, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Profile
Screening and Predictive Toxicology (8909).
Date: April 29, 2013.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
19499
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: March 26, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–07423 Filed 3–29–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information: The National
Toxicology Program Requests
Information On Assays and
Approaches Useful for Screening
Compounds for Potential Neurotoxicity
SUMMARY: The National Toxicology
Program (NTP) requests information on
medium- or high-throughput
technologies/assay systems, which
allow for the batch screening of
compounds (e.g., 25–50) in biochemicalor cell-based assays or alternative (nonrodent) animal models, that might be
used to prioritize compounds for in vivo
neurotoxicity testing.
DATES: The deadline for receipt of
information is May 1, 2013.
ADDRESSES: Information may be
submitted electronically or as printed
copy.
Electronic submissions: Email to
barbourp@niehs.nih.gov.
Print submissions: Send 4 copies to
Patrick J. Barbour, Contract Specialist,
National Institute of Environmental
Health Sciences (NIEHS), P.O. Box
12233 (MD K1–05), Research Triangle
Park, NC 27709. Courier address: 530
Davis Drive, Keystone Building, Room
1059, Morrisville, NC 27560.
FOR FURTHER INFORMATION CONTACT:
Patrick J. Barbour, Contract Specialist,
NIEHS, P.O. Box 12233 (MD K1–05),
Research Triangle Park, NC 27709.
Courier address: 530 Davis Drive,
Keystone Building, Room 1059,
Morrisville, NC 27560. Email:
barbourp@niehs.nih.gov.
SUPPLEMENTARY INFORMATION:
Background
For the purposes of this request for
information (RFI), neurotoxicity means
adverse outcomes to the nervous system
resulting from exposure during any life
stage. Special emphasis is placed on
identifying assay systems that
interrogate cellular and molecular
events that are critical to the
development and/or function of the
nervous system. The NTP is also
interested in receiving
E:\FR\FM\01APN1.SGM
01APN1
]]>Agencies
[Federal Register Volume 78, Number 62 (Monday, April 1, 2013)]
[Notices]
[Pages 19498-19499]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-07421]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary and Alternative Medicine;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Council for Complementary and Alternative Medicine.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Complementary
and Alternative Medicine.
Date: June 7, 2013.
Closed: 8:30 a.m. to 10:00 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Bethesda, MD 20892.
Open: 10:15 a.m. to 4:00 p.m.
Agenda: Report from the Institute Director and other business of
the Council.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Bethesda, MD 20892.
[[Page 19499]]
Contact Person: Martin H. Goldrosen, Ph.D., Director, Division
of Extramural Activities, National Center for Complementary and
Alternative Medicine, NIH, 6707 Democracy Blvd., Ste. 401, Bethesda,
MD 20892-5475, (301) 594-2014, goldrosm@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: nccam.nih.gov/about/naccam/, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.213,
Research and Training in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: March 26, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-07421 Filed 3-29-13; 8:45 am]
BILLING CODE 4140-01-P
